| Code | Display | Comments |
|---|
 DE19 | Vaccine type | |
| DE20 | Date and time of vaccination | |
| DE201 | Contact date | |
| DE202 | ANC contact number | |
| DE124 | Dose number | |
| DE156 | Immunization recommendation status | |
| DE157 | Not due | |
| DE158 | Due | |
| DE189 | Complete | |
| DE159 | Contraindicated | |
| DE160 | Further evaluation needed | |
| DE161 | Potential contraindications | |
| DE162 | Currently pregnant | |
| DE163 | Immunocompromised | |
| DE200 | Severely immunocompromised | |
| DE164 | Exposed to immunosuppressive treatment | |
| DE165 | Severely immunosuppressed | |
| DE187 | Immunodeficiency syndromes | |
| DE166 | History of anaphylactic reactions | |
| DE167 | Severe allergic reactions | |
| DE168 | Symptomatic HIV infection | |
| DE169 | Planning to get pregnant in the next month | |
| DE170 | Receiving blood products | |
| DE188 | Severe acute illness | |
| DE190 | TB disease | |
| DE191 | Breastfeeding | |
| DE192 | Spina bifida | |
| DE193 | Bladder exstrophy | |
| DE194 | Acute gastroenteritis | |
| DE195 | Moderate to severe fever | |
| DE196 | Prior history of intussusception | |
| DE197 | Altered immunocompetence | |
| DE198 | Hypersensitivity to vaccine components | |
| DE199 | Taking antibiotics | |
| DE86 | Client education and counselling on immunization | |
| DE87 | Counselling on functions of the immunological system | |
| DE88 | Advising about functions of the immunological system | |
| DE89 | Education to influence immunization behaviours | |
| DE90 | Advising about immunization behaviours | |
| DE91 | Awareness raising to influence immunization behaviours | |
| DE1 | Immunization event status | |
| DE2 | Completed | |
| DE3 | Entered in error | |
| DE4 | Not done | |
| DE5 | Reason vaccine was not administered | |
| DE6 | Immunity | |
| DE7 | Medical precaution | |
| DE8 | Product out of stock | |
| DE9 | Client objection | |
| DE10 | Caregiver refusal | |
| DE11 | Unspecified reason | |
| DE12 | Client allergy to vaccine or component | |
| DE13 | Immunocompromised | |
| DE14 | Chronic illness or condition | |
| DE15 | Acute illness | |
| DE16 | Had the disease | |
| DE17 | Immunization not carried out for other reasons | |
| DE18 | Vaccine brand | |
| DE173 | Live vaccine | |
| DE21 | Country of vaccination | |
| DE22 | Administrative area | |
| DE23 | Vaccine manufacturer | |
| DE24 | Vaccine batch number | |
| DE25 | Vaccine market authorization holder | |
| DE26 | Expiration date | |
| DE34 | Dose quantity | |
| DE35 | Health worker identifier | |
| DE125 | Total doses in series | |
| DE126 | Disease targeted | |
| DE127 | Typhoid | |
| DE128 | Influenza | |
| DE129 | Measles | |
| DE133 | Pertussis | |
| DE135 | Mumps | |
| DE136 | Varicella | |
| DE137 | Viral hepatitis A | |
| DE139 | Tuberculosis | |
| DE140 | Viral hepatitis B | |
| DE141 | Haemophilus influenzae type b | |
| DE142 | Tetanus | |
| DE143 | Rotavirus | |
| DE144 | Human papillomavirus | |
| DE175 | Japanese encephalitis | |
| DE146 | Poliomyelitis | |
| DE176 | Diphtheria | |
| DE177 | Pneumococcal disease | |
| DE178 | Rubella | |
| DE179 | Dengue | |
| DE180 | Rabies | |
| DE181 | Meningococcal | |
| DE182 | Cholera | |
| DE183 | Tick-borne encephalitis | |
| DE184 | Yellow fever | |
| DE148 | COVID-19 | |
| DE149 | Due date of next dose | |
| DE92 | Reaction reported | |
| DE93 | Reaction date | |
| DE95 | Reaction manifestation | |
| DE96 | Severe local reaction | |
| DE98 | Seizures | |
| DE99 | Abscess | |
| DE100 | Sepsis | |
| DE101 | Encephalopathy | |
| DE102 | Toxic shock syndrome | |
| DE103 | Anaphylaxis | |
| DE104 | Fever | |
| DE105 | Other | |
| DE107 | Type of reaction | |
| DE174 | Non serious | |
| DE108 | Death | |
| DE109 | Life threatening | |
| DE110 | Disability | |
| DE111 | Hospitalization | |
| DE112 | Congenital anomaly | |
| DE113 | Other important medical event (specify) | |
| DE115 | Reaction outcome | |
| DE116 | Died | |
| DE117 | Recovered | |
| DE118 | Recovered with sequelae | |
| DE119 | Recovering | |
| DE120 | Not recovered | |
| DE121 | Unknown | |
| DE185 | Date/time of follow-up appointment | |
| DE186 | Recommended follow-up date | |
| DE150 | Digital certificate needed | |
| DE151 | Certificate issuer | |
| DE152 | Health Certificate Identifier (HCID) | |
| DE153 | Certificate valid from | |
| DE154 | Certificate valid until | |
| DE155 | Certificate schema version | |
| DE263 | Birth dose | |
| DE258 | Type of dose | |
| DE259 | Primary series | |
| DE260 | Dose 0 | |
| DE261 | Supplementary dose | |
| DE262 | Booster dose | |
| DE203 | Completed the primary vaccination series | |
| DE257 | Completed the booster series | |
| DE242 | Date when primary vaccination series was completed | |
| DE204 | HIV status | |
| DE205 | HIV-positive | |
| DE206 | HIV-negative | |
| DE207 | Unknown | |
| DE208 | Preterm birth | |
| DE209 | Immunocompromised | |
| DE210 | Currently on ART | |
| DE243 | Type of TB infection test performed | |
| DE244 | IGRA | |
| DE245 | TST | |
| DE246 | TB infection test result | |
| DE247 | Positive | |
| DE248 | Negative | |
| DE249 | Immunologically stable | |
| DE250 | Clinically well | |
| DE211 | Birth weight in grams | |
| DE212 | Type of poliovirus dose | |
| DE213 | IPV | |
| DE214 | bOPV | |
| DE215 | ART start date | |
| DE251 | High risk of pneumococcal infection | |
| DE216 | Type of JE dose | |
| DE217 | Inactivated Vero cell-derived vaccine | |
| DE218 | Live attenuated vaccine | |
| DE219 | Live recombinant vaccine | |
| DE220 | Type of TBE dose | |
| DE221 | FSME-Immun | |
| DE222 | Encepur | |
| DE223 | TBE-Moscow | |
| DE224 | EnceVir | |
| DE225 | Type of typhoid dose | |
| DE226 | Typbar-TCV | |
| DE227 | ViPS | |
| DE228 | Ty21a | |
| DE229 | Type of cholera dose | |
| DE230 | WC vaccine | |
| DE231 | WC-rBS vaccine | |
| DE232 | Type of meningococcal dose | |
| DE233 | MenA conjugate vaccine (5µg) | |
| DE234 | Monovalent MenC conjugate | |
| DE235 | Quadrivalent conjugate | |
| DE252 | Polysaccharide vaccine | |
| DE236 | Age in months when client received first meningococcal dose | |
| DE237 | Type of hepatitis A dose | |
| DE238 | Live attenuated hepatitis A vaccine | |
| DE239 | Inactivated hepatitis A vaccine | |
| DE254 | Type of hepatitis B dose | |
| DE255 | Hepatitis B monovalent vaccine | |
| DE256 | Hepatitis B combination vaccine | |
| DE240 | VNA level | |
| DE253 | Risk of occupational exposure to rabies virus | |
| DE241 | Dengue serostatus | |
| DE264 | Positive | |
| DE265 | Negative | |
| DE266 | Unknown | |
jurisdiction[0]